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Epigenetics represents a secondary inheritance system that has been poorly investigated in human biology. The objective
of this study was to perform a comprehensive analysis of DNA methylation variation between and within the germlines
of normal males. First, methylated cytosines were mapped using bisulphite modification–based sequencing in the pro-
moter regions of the following disease genes: presenilins (PSEN1 and PSEN2), breast cancer (BRCA1 and BRCA2), myotonic
dystrophy (DM1), and Huntington disease (HD). Major epigenetic variation was detected within samples, since the
majority of sperm cells of the same individual exhibited unique DNA methylation profiles. In the interindividual analysis,
41 of 61 pairwise comparisons revealed distinct DNA methylation profiles ( to 6.8# 10514). Second, a microarray-Pp .036
based epigenetic profiling of the same sperm samples was performed using a 12,198-feature CpG island microarray. The
microarray analysis has identified numerous DNA methylation–variable positions in the germ cell genome. The largest
degree of variation was detected within the promoter CpG islands and pericentromeric satellites among the single-copy
DNA fragments and repetitive elements, respectively. A number of genes, such as EED, CTNNA2, CALM1, CDH13, and
STMN2, exhibited age-related DNA methylation changes. Finally, allele-specific methylation patterns in CDH13 were
detected. This study provides evidence for significant epigenetic variability in human germ cells, which warrants further
research to determine whether such epigenetic patterns can be efficiently transmitted across generations and what impact
inherited epigenetic individuality may have on phenotypic outcomes in health and disease.
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Phenotypic differences among individuals have tradition-
ally been attributed to genetic (DNA sequence) variation
and environmental differences. Over the past several de-
cades, documentation of DNA sequence variants has been
one of the top priorities in biomedical research. Numerous
major international projects—from the sequencing of the
Human Genome1,2 to the creation of SNP databases
(dbSNP, now called “Entrez SNP”) and the Haplotype Map3
(HapMap)—have contributed significantly to the under-
standing of the position, degree, and structure of DNA
polymorphisms. However, SNPs and other DNA sequence
differences are relatively rare, and DNA sequences of two
unrelated individuals are 99.5% identical. Furthermore,
only a small fraction of these polymorphisms are func-
tional—that is, polymorphisms that change amino acid
sequence in the protein or have an impact on gene ex-
pression. Sequencing of the chimpanzee (Pan troglodytes)
genome revealed 98.67% DNA sequence identity to the
human genome, and, again, only a fraction of polymor-
phisms appear to result in structural or functional gene
differences.4 Such findings raise the question: is this low
DNA sequence variation across unrelated individuals and
our closest related species sufficient to account for all ma-
jor differences in physiological and psychological phe-
notypic outcomes?
One potential, although poorly investigated, source of
phenotypic differences is epigenetic variation. By defini-
tion, “epigenetics” refers to the regulation of various ge-
nomic functions that are controlled by partially stable
modifications of DNA and chromatin proteins.5 Epigenetic
signals are critical to the proper functioning of the ge-
nome, as seen in Dnmt1-knockout mice that die in early
embryogenesis,6 in several rare pediatric syndromes, and
in cancer.7 One important feature of epigenetic regulation
is partial epigenetic stability, or metastability. Epigenetic
profiles in different cells of the same organism can be quite
different, and developmental programs, environmental
factors, or stochastic events in the nucleus of a cell can
induce this variation. The first systematic effort to docu-
ment DNA methylation differences and similarities across
different genome regions, the Human Epigenome Project,
was recently launched. The pilot study of the MHC locus
on chromosome 6 investigated seven cell types (adipose,
brain, breast, lung, liver, prostate, and muscle) across 32
individuals.8 In this study, which was not controlled for
sex and age, around half (118/253) of the tested loci
showed some interindividual variability in at least one
tissue. The next phase of the Human Epigenome Project,
which will be controlled for the above parameters, will
provide coverage of 15,000 loci (∼3,000 genes) from chro-
mosomes 6, 13, 20, and 22 across 120 tissue types.8 The
Human Epigenome Project and other smaller-scale studies
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have investigated epigenetic variation primarily in so-
matic cells. However, there has been very little effort to
document epigenetic variation in the germline, apart from
imprinted genes9,10 and isolated cases of germ cell
epimutations.11,12
There are several reasons to believe that the germline
may contain substantial epigenetic variation. Epigenetic
reprogramming during gametogenesis, fertilization, and
embryogenesis involves dramatic chromatin remodel-
ing.13 Methylation reprogramming during gametogenesis
involves the erasure and reestablishment of methylation
of imprinted genes and other nonimprinted genes and,
then, a second wave of reprogramming during fertilization
(paternal) and embryogenesis (maternal).13 This process is
thought to (1) ensure that both gametes acquire the ap-
propriate sex-specific epigenetic states and establish the
epigenetic states required for early embryonic develop-
ment and toti- or pluripotency and (2) allow the erasure
of epimutations that adult germ cells may have inherited
or developed during their lifetime.14,15 In parallel with
DNA methylation, chromatin changes during spermato-
genesis involve the compaction of the haploid genome by
the replacement of the core histones via transition pro-
teins to the much smaller basic protamines 1 and 2.16 How-
ever, a number of testis-specific histones and histone var-
iants—such as TSH2B, histones H2A, H3, and H4, variants
of H2B, and CENP-A—are present, to some extent, in the
mature spermatozoa.17–19 How these remaining histones
are arranged and to what extent interindividual variability
in histone placement and modification can affect devel-
opment and phenotype are subjects yet to be investigated.
Despite dramatic changes, not all epigenetic signals are
erased in the germline, and recent studies in mice have
suggested that this phenomenon could underlie epige-
netic inheritance.20,21 Therefore, there is ample opportu-
nity during these phases of reprogramming to either main-
tain or generate substantial epigenetic variability in the
germ cells.
Although there is evidence that some individual loci
exhibit partial epigenetic stability during meiosis in mice
and in other organisms, to further understand the degree,
mechanisms, and importance of epigenetic inheritance
across generations in humans, three main questions need
to be addressed in the following order. (1) Is there any
evidence for epigenetic variation in the germ cells? (2) To
what extent is the epigenetic variation meiotically stable?
(3) What is the impact of epigenetic variation in germ
cells on phenotypic differences? In this study, we at-
tempted to answer the first question by estimating the
intra- and interindividual epigenetic variation detectable
in the mature sperm of healthy individuals. For this goal,
we used two different laboratory strategies. The first ap-
proach focused on promoter regions of several disease-
related genes—such as PSEN1 (MIM 104311), PSEN2 (MIM
600759), BRCA1 (MIM 113705), BRCA2 (MIM 600185),
DM1 (MIM 160900), and HD (MIM 143100)—in healthy
individuals, with the use of bisulphite modification–based
mapping of methylated cytosines and measured epige-
netic “distances” between individuals. The second strategy
was to perform a microarray-based epigenetic profiling of
sperm DNA with the use of a CpG island microarray,
which provides genomewide information on methylation
variability across different unique and repetitive DNA se-
quences. Several loci of interest identified in the microar-
ray experiments were further investigated using methyl-
ation-sensitive single-nucleotide primer extension (MS-
SNuPE) reaction.
Material and Methods
Samples
Two sperm sample sets were used in this study. The first sample
set was received from the Fairfax Cryobank, Genetics & IVF In-
stitute, in Fairfax, VA, and consisted of 25 sperm samples collected
from healthy white sperm donors at an average age of 27 years
(range 22–35 years). The second set of sperm samples was col-
lected at the Centre for Addiction and Mental Health in Toronto
from 21 healthy white individuals at an average age of 39 years
(range 24–56 years). This study was approved by an institutional
ethics board, and informed consent was obtained from all par-
ticipants. Some aspects of sperm DNA data analysis required a
nonsperm tissue of reference; for this purpose, postmortem brain
tissues were used (donated by The Stanley Medical Research In-
stitute’s brain collection, courtesy of Drs. M. B. Knable, E. F. Tor-
rey, M. J. Webster, S. Weis, and R. H. Yolken). These brain samples
were from 22 white males who had an average age at death of
46 years (range 31–66 years). Extraction of DNA was performed
using standard salt and phenol/chloroform extraction.
Bisulphite Modification–Based Mapping of Methylated
Cytosines
Bisulphite modification–based mapping of methylated cytosines
was performed as described elsewhere.22 In brief, genomic DNA
(700 ng) was digested with BglII (Fermentas) for 1 h at 37C, was
denatured at 100C for 5 min, was chilled on ice, and was then
incubated at 50C for 15 min in 0.3 M NaOH. The DNA was then
mixed with 2% low–melting point agarose (SeaPlaque Agarose,
FMC) and was dropped into ice-cold mineral oil to form seven
beads of ∼10 ml, and, finally, the beads were placed into a freshly
prepared solution containing 2.5 M sodium bisulphite (pH 5.0)
plus 1 mM hydroquinone (both from Sigma). The beads were
then incubated on ice for 30 min, followed by incubation at 50C
for 3.5 h. The beads were washed in four changes of Tris-EDTA
(TE) (pH 8.0) for 1 h and then were desulphonated in 0.2 M NaOH
for 30 min. After desulphonation, the beads were washed a second
time in three changes of TE for 30 min. Before amplification, the
beads were washed in H2O for 30 min. PCR amplification of the
target sequences consisted of 5 ml of agarose beads containing the
bisulphite-treated DNA, 2 mM MgCl2, 0.2 mM deoxynucleotide
triphosphates (dNTPs), 0.4 mM each of forward and reverse
primer, 250 ng/ml BSA, and 2.5 U Taq polymerase (New England
Biolabs) in 1# PCR buffer, to a total volume of 50 ml. PCR was
performed using either a seminested or a fully nested approach,
with the first PCR consisting of one cycle at 97C for 4 min, 53C
for 2 min, and 72C for 2 min, followed by 24 cycles at 94C for
45 s, 53C for 1 min, and 72C for 1 min. The second PCR used
5 ml of the first PCR as a template and consisted of one cycle at
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Table 1. Primer Sequences
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
97C for 2 min, 53C for 2 min, and 72C for 1 min, followed by
24 cycles at 94C for 45 s, 55C for 45 s, and 72C for 1 min. CpG
islands in the 5′ promoter sequences were analyzed in six genes:
PSEN1 (Entrez GeneID 5663; chromosome 14: 72672525–
72673163), PSEN2 (GeneID 5664; chromosome 1: 223365273–
223365990), BRCA1 (GeneID 672; chromosome 17: 38530561–
38531181), BRCA2 (GeneID 675; chromosome 13: 31787367–
31788153), HD (GeneID 3064; chromosome 4: 3113281–
3113816), and DM1 (GeneID 1760; chromosome 19: 50964670–
50965254). An intronic CpG island within the CDH13 gene
(GeneID 1012; chromosome 16: 81218597–81218988) was also
analyzed by bisulphite genomic sequencing. Nucleotide positions
given are from the May 2004 Genome (hg17) version (UCSC Ge-
nome Browser). The primers used for amplification of bisulphite-
modified DNA fragments are available in table 1.
PCR products were electrophoresed on an agarose gel. DNA
fragments were excised, were cleaned using Qiagen Gel Extraction
Kit (Qiagen), and were cloned into the pGEM-T vector (Promega).
Thirty clones from each PCR product (locus/individual) were se-
quenced. To evaluate the degree of intraindividual variation, we
sequenced an additional 30 clones from separate bisulphite re-
actions in five cases: two in BRCA1, one in BRCA2, and two in
PSEN2. A total of 1,020 clones were analyzed, which required
11,500 sequencing reactions, since some longer fragments had to
be sequenced from both ends.
Analyses of DNA Methylation Variation in Bisulphite
Modification–Based Experiments
The degree of epigenetic diversity within and across individuals
was evaluated using the concept of epigenetic “distance.”23 Each
of the 30 sequenced clones was binary coded, with “0” for an
unmethylated cytosine and “1” for a methylated cytosine. Each
clone was, therefore, represented by a row vector of n 0 and 1,
where n is the number of cytosines in the tested region.
Estimation of intraindividual variation.—Unique methylation pro-
files were identified for each set of 30 clones. For example, a set
of clones 0101, 0101, 0111, and 1100 exhibits three types of
methylation profiles (1/2, 3, and 4), and, therefore, the propor-
tion of unique methylation profiles is 3/4. This calculation was
performed for every set of 30 clones, and then the mean and SD
of the proportion of unique clones across individuals were cal-
culated for each locus. In the second round of analysis, because
of possible imperfect CrT conversion with bisulphite treatment,
two clones different by a single position were treated as identical.
With use of the above example, profiles 0101 and 0111 are now
treated as identical, and the degree of uniqueness is 2/4. In the
final analysis, the tolerance was increased to two differences—
that is, the clones that exhibited two or fewer differences were
treated as identical.
Comparison of DNA methylation distances across individuals.—The
average methylation-intensity vector for each locus/individual
was calculated by dividing the sum of the methylated cytosines
by 30 for each different cytosine position. The degree of epige-
netic dissimilarity was measured by Euclidean distance, by use of
the following equation:
n
2d p (m m ) ,12 1i 2i
ip1
where m1 is the average methylation vector of individual 1, m2
is the average methylation vector of individual 2, and d12 is the
Euclidean DNA methylation distance between individuals 1 and
2. The larger the distance, the more dissimilar the two individuals’
methylation profiles are to each other. With this metric, we cal-
culated the distances between all possible pairs of individuals for
each promoter locus of BRCA1, BRCA2, HD, DM1, PSEN1, and
PSEN2. To test statistical significance of methylation differences,
we performed the following analysis. For each locus, all clones
from all individuals were pooled together, and two sets of 30
randomly selected clones from the pool formed the methylation
profiles of two pseudo-individuals. The epigenetic distance be-
tween the two pseudo-individuals was then calculated with the
same procedure as above, and this procedure was repeated
100,000 times to generate 100,000 distances, the density distri-
bution of which was plotted, and the mean (2 SD) was calcu-
lated. The (one-tailed) P value of a distance was then obtained
by finding the area under the distribution curve, from the left up
to the calculated distance. An epigenetic distance in two real
individuals with (i.e., 12 SD) indicates that difference inP ! .05
the DNA methylation of two individuals is statistically significant.
Microarray-Based DNA Methylation Analysis
Microarrays.—Genomewide epigenetic profiling was performed
using the 12,192 CpG island microarrays24 purchased from the
University Health Network Microarray Facility in Toronto.
Enrichment of unmethylated DNA.—We used our developed tech-
nology for enrichment of the unmethylated DNA fraction and
for epigenetic profiling described in detail elsewhere.25 The gen-
eral principle of the DNA methylation profiling consists of in-
terrogation of the unmethylated fraction of genomic DNA on the
microarray. Intensity of hybridization inversely correlates with
the DNA methylation status at the genomic locus homologous
to a specific DNA fragment on the array. In brief, methylation-
sensitive restriction enzymes were used to digest 1 mg of genomic
DNA, and two enzyme scenarios were used in this project. First,
sperm DNA samples from 25 individuals were analyzed using
methylation-sensitive enzymes HpaII, Hin6I, and AciI (designated
“sperm DNA–HHA array” set). This enzyme “cocktail” strategy,
however, is not ideal for GC-rich regions, such as CpG islands,
since these three enzymes would generate DNA fragments too
small for efficient amplification and hybridization. Therefore, a
single-digestion approach with HpaII alone was used on a second
set of sperm DNA samples from 21 individuals (designated “sperm
DNA–HpaII” array set). DNA adaptors (annealing products of two
primers, U-CG1a [5′-CGTGGAGACTGACTACCAGAT-3′] and U-
CG1b [5′-AGTTACATCTGGTAGTCAGTCTCCA-3′]) were ligated
to the restricted DNA fragments, followed by treatment with
McrBC (New England Biolabs), which cleaves the fragments con-
taining two or more methylated cytosines, thereby further en-
riching the unmethylated fraction. Adaptor-PCR amplification of
the ligated products, with the use of primers complementary to
the adaptor sequence, consisted of 250 ng of ligated DNA, 2.5
mM MgCl2, 0.2 mM aminoallyl-dNTPs (15 mM aminoallyl–2
′-
deoxyuridine 5′-triphosphate, 10 mM 2′-deoxythymidine 5′-tri-
phosphate, and 25 mM each of 2′-deoxycytidine 5′-triphosphate,
2′-deoxyguanosine 5′-triphosphate, and 2′-deoxyadenosine 5′-tri-
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phosphate), 200 pmol primer U-CG1b, and 5 U Taq polymerase
(New England Biolabs) in 1# PCR reaction buffer (Sigma), to a
final volume of 100 ml. PCR conditions are adjusted in such a way
that only fragments !1.5 kb (i.e., short, digested, and, therefore,
unmethylated) will amplify preferentially. Cycling consisted of
an initial cycle at 72C for 5 min and 95C for 1 min, 25 cycles
at 95C for 40 s and 68C for 2 min 30 s, and a final extension
at 72C for 5 min. Equal amounts of amplicons from each sample
were mixed to form the pooled control, which was labeled with
Cy3 and was cohybridized against each individual amplicon la-
beled with Cy5. Hybridization was performed at 42C with the
use of standard procedure.25
For comparison with the sperm DNA methylation profiles,
DNA samples from postmortem brains of 22 individuals who did
not have any known brain disease were subjected to the same
microarray-based DNA methylation profiling that used a single-
digestion approach with HpaII (designated “brain DNA–HpaII”
array set).
Microarray data processing and analysis.—Methylation differences
between the individuals and the pooled control were analyzed
by the ratio of hybridization intensities of Cy5 (individual sam-
ples) over Cy3 (pooled control). As we have learned from our
previous analyses of arrays used for DNA methylation analysis,
such ratios show normal distribution; therefore, the data can be
treated similarly to those in classical microarray experiments. The
array data were normalized in two steps—first, in a global inten-
sity normalization, to adjust the Cy5:Cy3 ratio to 1:1 across the
entire array, followed by a block-by-block LOWESS normalization.
The data were trimmed to remove spots with ambiguous genome
locations, including spots with no sequence or annotation (647
spots), spots with 130% repetitive elements (2,706 spots), and
translocation hotspots (633 spots). The spots for which the mi-
croarray clones represented identical sequences were averaged,
which resulted in ∼4,970 unique loci. Coefficient of variation
(CV) was calculated for each remaining spot by dividing the SD
in Cy5/Cy3 by the mean of Cy5/Cy3 across all individuals. The
sperm DNA–HHA experiments were performed in duplicate, and
the data were averaged ratios. The sperm DNA–HpaII and the
brain DNA–HpaII data sets consisted of one array per individual,
because we opted for increased biological replicates rather than
for increased technical replicates for the number of microarrays
available.
Age-covariate analysis.—For the CpG island microarray experi-
ment, the age-covariate analysis was performed using a correla-
tion coefficient between two series of quantities, to measure the
linear relationship between the series. Pearson correlation coef-
ficient was calculated between the mean fold change (log Cy5/
Cy3) across individuals and the ages across individuals, for each
spot on the microarray. A large absolute value ( ) of theFrF 1 0.5
coefficient indicates that the methylation intensity at the locus
covariates with age in a positive or a negative way. To test their
statistical significance, the ages across individuals were permuted,
and, again, the coefficients were computed using the permuted
age series. For each spot, the permutation was repeated 5,000
times to get 5,000 coefficients. The one-tailed P value of the co-
efficient was then obtained by finding the fraction of times that
the coefficients were larger (or smaller) than the original coeffi-
cient. Although a P-value cutoff at .05 may lead to many false
positives, the adjustment of P value for multiple testing, by con-
trolling the probability of making at least one false positive, dra-
matically lowers the power of the experiment and is also consid-
ered too conservative for microarray studies.26 “False discovery
rate” (FDR) is defined as the expected proportion of false-positive
predictions among the positive predictions. For example, in the
100 positives declared by FDR at 0.1, 90 are expected to be true
positives on average. The FDR criterion has increasingly been
adopted over P value in microarray analysis. We have, therefore,
applied FDR for the findings described in this article.
The autocorrelation clustering analysis for the CpG island mi-
croarray experiment was performed using the autocorrelation
function ACF(x), which measures how strongly two methylation
intensities x loci apart influence each other.
Measurement of Densities of Methylated Cytosines in the
Selected Loci
Further analysis of a selected set of DNA fragments identified as
the most variable was performed using the MS-SNuPE reaction
on the ABI SNapShot platform accommodated for measuring the
C/T ratios in the bisulphite-treated genomic DNA.27 In brief, ge-
nomic DNA was digested with NdeI (Fermentas), followed by
treatment with sodium bisulphite, as described above. The loci
of interest were amplified using nested PCR (primers available in
table 1). Typical PCR amplification consisted of one cycle at 95C
for 1 min, then 40 cycles at 95C for 30 s, 50C for 30 s, and 72C
for 40 s, followed by a final extension at 72C for 5 min. Quan-
titative interrogation of the bisulphite-induced CrT transition at
CpG dinucleotides in such amplicons was performed with prim-
ers targeted to the CpG dinucleotides within the restriction sites
for HpaII, Hin6I, or AciI.
Results
Intra- and Interindividual DNA Methylation Differences in
the Promoters of BRCA1, BRCA2, HD, DM1, PSEN1, and
PSEN2
The bisulphite modification–based mapping of methyl-
ated cytosines for all of these genes demonstrated that
numerous individual clones (representing individual
sperm cells) demonstrated quite different DNA methyla-
tion profiles within individuals (fig. 1A). This finding was
confirmed by the analysis of the degree of uniqueness of
DNA methylation profiles (fig. 1B). In the case of HD,
∼80% of all clones exhibited unique patterns of methyl-
ated cytosine distribution. This estimate did not change
dramatically when potential bisulphite modification–in-
duced artifacts were taken into account; on average, 72%
of clones were different from one another when one meth-
ylated cytosine difference was tolerated, and up to 53%
were different when two differences were allowed. The
latter situation is a very conservative estimate of the de-
gree of uniqueness, since such a high artifactual CrT non-
conversion rate is unrealistic. In our experiments, the ar-
tifactual CrT bisulphite conversion was always !1%. The
lowest degree of intraindividual DNA methylation unique-
ness was detected for PSEN2: 36%, 20%, and 13% for 0,
1, and 2 levels of tolerance, respectively. This analysis of
uniqueness is, however, related to the clone length and
correlates specifically with the density of the CpGs ana-
lyzed (Pearson , 0.93, and 0.98 for 0, 1, and 2Rp 0.64
levels of tolerance, respectively), since more methylatable
CpG sites allow more opportunity for variation.
Figure 1. Intraindividual variability of DNA methylation. A, DNA methylation profiles of the promoter CpG islands of BRCA1 and PSEN2,
determined on the basis of sequencing 60 clones of bisulphite-modified sperm DNA. The BRCA1 locus covered 32 CpGs, and the PSEN2
region included 45 CpGs. Nine monomorphic (unmethylated) CpGs (BRCA1 or PSEN2) were excluded from the figure. Each individual is
represented, with individual CpG dinucleotides from left to right (blackp methylated cytosines; whitep unmethylated cytosines) and
individual clones from top to bottom. Like the presented BRCA1 and PSEN2 cases, a substantial proportion of clones in other loci (HD,
DM1, BRCA2, and PSEN1) revealed unique DNA methylation profiles. B, Estimates of the proportion of unique methylation profiles in
the promoter regions of the six analyzed genes. The Y-axis shows the proportion of clones carrying unique methylation profiles over
the total number of sequenced clones; the X-axis shows the proportion of unique profiles that contain at least 1, 2, and 3 differences
(left, middle, and right bars, respectively), compared with the other profiles at the same locus in the same individual.
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Figure 2. Interindividual variability of DNA methylation in six human disease genes. Bisulphite modification–based mapping of
methylated cytosines in BRCA1, BRCA2, HD, DM1, PSEN1, and PSEN2. Thirty individual clones were sequenced from three to seven
individuals. Analysis for each gene is represented in two panels. Left panels, graphical profile of the percentage of methylation (Y-axis,
ranging from 0% to 40%) for every CpG dinucleotide (X-axis, ranging from 32 to 108 CpG dinucleotides), out of the total number of
clones for each individual. Right panels, Euclidean distances (Y-axis) of pairwise comparisons between individual methylation profiles
(X-axis). The blue line is the mean distance, and red lines are 2 SD from the mean, both obtained for each gene from the permutation
study (see the “Material and Methods” section). Pairwise comparisons are annotated—for example, as “16”—for the comparison of the
Euclidean distance of individual 1 with that of individual 6. Primed individual numbers (e.g., 4′) represent a second set of 30 clones
from those individuals. The error bars on some data points represent SDs from 100,000 permutations of 30 clone groups from the
individuals from whom 60 clones were sequenced.
Whereas the intraindividual analysis can show vari-
ability within an individual, significantly variable meth-
ylation patterns between individuals were also revealed
(fig. 2). The gene-specific results were as follows: in BRCA1,
, 32 CpGs were analyzed, and 5/6 pairwise compar-np 4
isons exhibited statistically significant differences (average
); in BRCA2, , 36 CpGs were ana-5Pp 2.53# 10 np 4
lyzed, and 3/6 pairwise comparisons were significant (av-
erage ); in PSEN1, , 43 CpGs were7Pp 8.56# 10 np 3
analyzed, and 2/3 pairwise comparisons were significant
(average ); in PSEN2, , 45 CpGs were4Pp 1.89# 10 np 5
analyzed, and 6/10 pairwise comparisons were significant
(average ); in DM1, , 99 CpGs were3Pp 5.11# 10 np 7
analyzed, and 13/21 pairwise comparisons were signifi-
cant (average ); and, in HD, , 1084Pp 5.60# 10 np 6
CpGs were analyzed, and 12/15 pairwise comparisons
were significant (average ). Overall, 67%3Pp 1.66# 10
(41/61) of the pairwise comparisons were significantly dif-
ferent, which suggests a high overall level of interindivi-
dual variability in the methylation patterns of the tested
genes. For the five cases in which 60 sequenced clones
were available for BRCA1, BRCA2, and PSEN2, the com-
parisons were performed using two randomly selected
groups of 30 clones (fig. 2). As a validation of this statisti-
Table 2. Statistical Analysis of Microarray Data from the Sperm DNA–
HHA, Sperm DNA–HpaII, and Brain DNA–HpaII Data Sets
Descriptive Statistics
Sperm
DNA–HHA
( )np 25
Sperm
DNA–HpaIIa
( )np 21
Brain
DNA–HpaII
( )np 22
Mean CV (SD)b 6.72 (2.48) 9.23 (4.92) 10.89 (5.40)
Loci countc 4,969 4,947 4,952
90th percentile (%)d 19.53 113.71 116.33
10th percentile (%)d !4.33 !5.16 !6.44
SNP analysise:
90th percentile:
No. with SNPs 78 32 ND
No. with no SNPs 72 118 ND
10th percentile:
No. with SNPs 74 22 ND
No. with no SNPs 76 128 ND
x2 .12 1.829 ND
P value .729 .176 ND
CGI analysisf:
Count:
CGI 2,523 2,512 2,478
Non-CGI 2,446 2,435 2,401
Mean CV (SD):
CGI 6.69 (2.57) 9.6 (5.28) 11.06 (4.94)
Non-CGI 6.79 (2.32) 8.97 (4.39) 11.05 (5.60)
t Test P value .14815 64.92# 10 .93995
CGI x2 testg:
90th percentile:
No. CGI 235 296 256
No. non-CGI 217 198 238
10th percentile:
No. CGI 226 218 255
No. non-CGI 209 277 238
x2 .003 24.34 .001
P value .955 75.81# 10 .974
Promoter x2 testg:
90th percentile:
No. promoter CGI NA 245 NA
No. non–promoter CGI NA 52 NA
10th percentile:
No. promoter CGI NA 152 NA
No. non–promoter CGI NA 67 NA
x2 NA 11.44 NA
P value NA 44.87# 10 NA
a Values in bold type are statistically significant.
b The mean (SD) of the CV in ratio Cy5/Cy3 across the individuals (n) for each data
set was calculated.
c The count represents the number of unique loci remaining after data trimming (see
the “Material and Methods” section).
d Loci with CVs 190th percentile are in the top 10% of methylation-variable regions,
and loci with CVs !10th percentile are the least variable loci.
e The SNP analysis was performed to test for the effects of SNPs from our DNA methylation
analysis. We randomly selected 300 loci from the 10th and 90th percentile loci, and the
clone sequence plus 1-kb flanking regions were screened for the presence of SNPs—in
particular, SNPs that create or disrupt HpaII, Hin6I, and AciI restriction sites. ND p not
done.
f The CpG island (CGI) analyses were performed by separating loci into either CGI or
non-CGI categories. A Student’s t test was performed to analyze the difference in mean
CV. The numbers of loci within each group in the 90th and 10th percentile loci were
counted, and x2 analysis was performed.
g The CGI loci were further subdivided into loci within promoter regions of genes or
loci not within promoters, the numbers of loci in the 90th and 10th percentiles were
counted, and x2 analysis was performed. NAp not applicable.
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Figure 4. Genomewide view of brain DNA–HpaII and sperm DNA–
HHA data sets. The legend is available in its entirety in the online
version of The American Journal of Human Genetics.
Figure 3. Chromosomal view of methylation variability by CpG island microarray analysis. A, Unmethylated fraction of genomic DNA
extracted from sperm samples ( ) hybridized individually (Cy5), in contrast to the pooled reference control (Cy3). The CV of thenp 21
Cy5/Cy3 ratio was calculated for each spot across the 21 individuals and was mapped to the corresponding genomic location. Each
chromosome ideogram is overlaid with red bars that represent the position of each clone on the CpG island microarray. The bars
highlighted in green are the loci that showed variance in the 90th percentile (the top 10% of loci exhibiting the largest degree of
DNA methylation variation). B, Screenshot of the custom annotation track on the UCSC Genome Browser (available from the Center for
Addiction and Mental Health). Shown is chromosome 6, which includes the major histocompatibility complex locus that was screened
for epigenetic variability by the Human Epigenome Project pilot study.8
cal method, the additional sets of 30 clones representing
BRCA1, BRCA2, and PSEN2 were compared with the pri-
mary sets of 30 clones of the same individuals. In all cases,
the results (compare pairs 55′ and 66′ in BRCA1 in fig. 2)
showed that their profiles were not different, which is to
be expected since they are from the same individual.
DNA Methylation Differences Detected by the CpG Island
Microarrays
This CpG island microarray contains 12,192 DNA frag-
ments; however, unique sequences are represented by
4,970 distinct loci, of which only about half meet the
commonly used criteria for CpG islands: GC content of
50%, length 1200 bp, and observed/expected CG di-
nucleotide ratio 10.6.28 As described in the “Material and
Methods” section, we used two strategies to increase the
informativeness of our microarray analysis. The first strat-
egy was to use an enzyme cocktail of HpaII, Hin6I, and
AciI (sperm DNA–HHA data set), which is more informa-
tive for lower GC content loci, such as those that do not
meet the CpG island criteria. The second strategy was to
use HpaII alone (sperm DNA–HpaII data set), which would
be more informative for the higher GC-containing loci.
Lastly, we analyzed a brain DNA microarray data set (brain
DNA–HpaII data set), to compare tissue-specific differ-
ences. As a measure of methylation variation, we have
calculated the CV across individuals for each array set. The
CV is calculated by dividing the SD in the Cy5/Cy3 ratio
by the mean of the Cy5/Cy3 ratio, and it is expressed as
a percentage. The variation in CV among individuals
across the genome ranged from 2.1% to 30.5% (meanp
), from 0.8% to 66.2% ( ), and from6.7% meanp 9.2%
2.1% to 97.4% ( ) for the sperm DNA–HHA,meanp 10.9%
sperm DNA–HpaII, and brain DNA–HpaII data sets, re-
spectively (table 2). We considered the loci within the top
10% of CVs (90th percentile) as highly variable regions.
The data for each locus were plotted on the genome
(figs. 3 and 4) and are also available online as a custom
annotation track (Center for Addiction and Mental
Health) with use of the UCSC Genome Browser (fig. 3B).
Figure 3A depicts the sperm DNA–HpaII data set and high-
lights the highly variable regions on the genome. To assess
whether this distribution of highly variable spots is non-
random, we performed an autocorrelation analysis; how-
ever, this analysis did not identify any evidence for au-
tocorrelation, most likely because of the large genomic
distance between microarray clones (average 0.6 Mb).
Other analyses included testing if the detected variability
is confounded by DNA sequence variation; comparison of
DNA methylation variation in CpG islands and in non–
CpG islands, as well as across different classes of repetitive
elements; and assessing if DNA methylation variation cor-
relates with the GC content, clone length, or particular
chromosomal cytobands.
Exclusion of Genetic Confounding Effects: SNPs and
Copy-Number Polymorphisms
Any method that relies on restriction-enzyme digestion
to differentiate between methylated and unmethylated
DNA can be influenced by SNPs within the enzyme-re-
striction sites. Therefore, from each of the sperm DNA–
HHA and sperm DNA–HpaII data sets, we selected 150
highly variable loci and 150 conserved loci and performed
in silico screening, to identify all known SNPs within a 2-
kb region of the selected clone that disrupt or create HpaII,
Hin6I, or AciI enzyme sites for the sperm DNA–HHA data
set or just HpaII sites for the sperm DNA–HpaII data set
(SNP annotation of the UCSC Genome Browser). If SNPs
were a significant confounding factor in DNA methylation
variation, we would expect a higher proportion of SNPs
in highly variable loci (e.g., 90th percentile) compared
with the lowest variable loci (e.g., 10th percentile). The x2
analysis revealed no association between the number of
potentially disruptive enzyme-restriction sites and the
degree of variability in either data set (sperm DNA–HHA
, ; sperm DNA–HpaII ,2 2x p 0.12 Pp .729 x p 1.83 Pp
). This finding suggests that the degree of variability.176
in the sperm DNA microarray analysis is more dependent
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on DNA methylation differences than on DNA sequence
differences.
Recent reports have identified 1200 copy-number poly-
morphisms (CNPs) that represent large duplications and
deletions that contribute significantly to genomic varia-
tion between individuals.29–31 Like SNPs, CNPs could sim-
ulate DNA methylation variability in the microarray anal-
ysis. We have cross-referenced the CNPs identified in these
studies with the CpG island microarray loci and have iden-
tified 25 microarray loci that occur within known CNP
regions. These include large CNPs in chromosomes 3 (cov-
ering the genes OSTa, AB018337, UNQ3030, BC015560,
and DLG1), 16 (BC008967, XYLT1, ARL61P, MIR16,
MGC16943, and CDR2), and 17 (AY302137, BHD, RAI1,
FLJ20308, TOP3A, and SMCR8) and smaller CNPs on chro-
mosomes 1 (NEGR1), 2 (AK024244), 6 (RDBP), 8 (TSTA3),
9 (LHX2), 11 (TNNT3), and 14 (AK090461). Microarray
results for these genes listed could, therefore, be influ-
enced by deletions or duplications as much as by meth-
ylation variability; however, none of these loci appear in
the list of highly variable (190th percentile) loci.
CpG Island Analysis
Not all DNA fragments on the CpG island microarray met
the criteria for CpG islands. The list of loci were divided
into “CpG islands” or “non–CpG islands,” and a Student’s
t test was performed to test for any statistically significant
difference in the mean CV (table 2). A significantly in-
creased DNA methylation variability was found in loci
defined as CpG islands in the sperm DNA–HpaII data set
(t test ), and this variability was exempli-6Pp 4.92# 10
fied by a bias towards CpG islands in the 90th percentile
(highly variable regions) ( ; ). In2 7x p 24.34 Pp 5.81# 10
addition, when the CpG islands were split into promoter
CpG islands and CpG islands not associated with known
gene promoters, significantly higher variability in pro-
moter CpG islands ( ; ) was de-2 4x p 11.44 Pp 4.87# 10
tected. However, analyses of methylation variability with
other measures, including GC percent alone and clone
length, did not reveal any association. No evidence for
higher DNA methylation variation was detected in the
promoter CpG islands in the brain DNA–HpaII data set,
and there also was no association with SNPs. Therefore,
this sperm DNA–HpaII experiment appears to have re-
vealed genuine increased methylation differences in the
promoter CpG islands.
Cytoband Analysis
It has been well described that different cytobands could
have evolved in different ways and that the genes within
each band could have evolutionary similarities.32,33 Since
these bands are based on, among other things, GC content
and Alu content, we sought to identify whether methyl-
ation variability was one of the aspects that showed sim-
ilarities within bands. The CpG island microarray anno-
tation includes the division of loci into different cyto-
bands, including the G bands (Giemsa negative: gneg) and
the four classes of R bands (Giemsa positive: gpos25,
gpos50, gpos75, and gpos100). These bands are defined as
follows. The darkest R bands, gpos100, are very rich in
GC and Alu; the next darkest, gpos75, are very rich in GC
but not in Alu; gpos50 are not rich in GC but are rich in
Alu; and gpos25 are Giemsa-dark bands that are rich in
neither GC nor Alu.34 Mean CVs for all the loci within
each of these cytobands were calculated, and a Student’s
t test was performed to identify any statistically significant
differences. In each of the data sets, marginally significant
associations with certain cytobands were identified. In the
sperm DNA–HHA data set, significant decreases in vari-
ability between gpos75 band loci (CV p 6.51) and the
other three R bands—gpos25, gpos50, and gpos100 (av-
erage CVp 6.83; average )—were detected. In thePp .023
sperm DNA–HpaII data set, gpos25 exhibited a lower de-
gree of methylation compared with gpos50 (CV p 8.97
and CVp 9.50, respectively; ). Although the sig-Pp .041
nificance of these statistical tests diminished when cor-
rected for multiple testing, the result is suggestive of an
increase in variability in the Alu-rich cytobands, such as
the gpos50 and gpos100 cytobands, compared with the
Alu-poorer bands gpos25 and gpos75.
Age-Dependent DNA Methylation Changes in the Sperm
Methylation dynamics with age (sperm DNA–HHA age
range 22–35 years; sperm DNA–HpaII age range 24–56
years) as a covariate were investigated. Individuals were
ordered by increasing age, and the Pearson correlation
between the age and relative methylation-signal intensity
(ratio of case to reference) was calculated for each locus.
In the sperm DNA–HpaII and sperm DNA–HHA data sets,
105 and 8 loci, respectively, were found, whose absolute
correlation coefficients were 10.5 and whose P values were
!.05. Numerous genes were identified in the germ cell data
that corresponded to genes involved in spermatogenesis
and development (e.g., INSM1, TZFP, and EED) and neu-
rogenesis (e.g., CALM1, STMN2, ARHGEF9, and ARX) or
to disease-related genes (e.g., MAF, DCC, and CDH13 [MIM
601364]). A number of examples are shown in figure 5.
The lists of genes for each data set are available in tables
3 and 4.
DNA Methylation in the Repetitive Elements
All the above analyses were performed on unique DNA
sequences; however, the CpG island microarray also con-
tains a large number of clones containing repetitive ele-
ments, which, as a rule, are heavily methylated.35 Al-
though it is difficult to directly distinguish between
methylation and copy-number differences, one possible
approach is to compare methylation of repetitive elements
in the sperm to that in other tissues. For this reason, the
sperm DNA–HpaII data set was analyzed in comparison
with the brain DNA–HpaII data set. The microarray loci
that contain a single repetitive element were separated
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Figure 5. Age-related DNA methylation changes in the sperm.
Individuals were ordered by increasing age (top left panel), and
gene-specific DNA methylation dynamics were investigated using
the individual ages (sperm DNA–HpaII age range 24–56 years) as
a covariate. Pearson correlation was calculated for each locus, and
the one-tailed P value of the coefficient was obtained. In the
sperm DNA–HpaII data set, 105 loci were identified as significantly
( ) correlated ( ) or inversely correlated ( ) withP ! .05 r 1 0.5 r !0.5
age. Since the unmethylated fraction of DNA was interrogated,
positive correlation indicates decreasing DNA methylation with
age, whereas inverse correlation reflects increasing methylation
with age. The genes CTNNA2, EED, CALM1, CDH13, and STMN2 are
shown as examples. Other genes for the sperm DNA–HpaII, sperm
DNA–HHA, and brain DNA–HpaII data sets are available in tables
3 and 4.
Table 3. Age-Related Correlation in Sperm
DNA–HpaII Data Set
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Table 4. Age-Related Correlation in Sperm
DNA–HHA Data Set
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
into each repeat class, and the mean CV (SD) was cal-
culated. If the repetitive elements were influencing the
methylation variability, one would expect that those loci
containing repetitive elements would display significantly
different mean CVs than those of nonrepetitive loci. This
analysis revealed the overall average repetitive-element
CV of 10.5 in the sperm, compared with the overall av-
erage CV in nonrepetitive elements of 9.6. The breakdown
of CV for each type of repetitive element represented on
the microarray is shown in figure 6. This analysis identi-
fied that satellite DNA repeats were statistically more var-
iable than other repetitive elements in the sperm DNA–
HpaII data set ( ). In comparison, this17Pp 6.12# 10
effect was far less pronounced in the brain DNA–HpaII
data set ( ) (fig. 6A). When the satellite repeatsPp .0027
were further separated into specific repeat classes, a num-
ber of repeat classes, predominantly centromeric or peri-
centromeric satellite repeats, were identified as responsible
for this increase in interindividual variability, including
(GAATTC)n ( ), ALR/a (human a-repetitive DNACVp 18.5
[ ]), CER (human D22Z3-centromeric–repetitiveCVp 25.0
DNA [ ]), and HSATII repeats (human satellite IICVp 18.7
DNA [ ]) (fig. 6B).CVp 34.8
Validation of the Microarray Data with Use of Bisulphite
Modification–Based Methylated/Unmethylated Cytosine
Analysis
For validation of the microarray data, 12 loci that were
detected as variable in the CpG island microarray analysis
(table 5) were analyzed using the MS-SNuPE reaction on
the ABI SNapShot platform27 at the CpG dinucleotides in
the HpaII and the Hin6I or AciI restriction sites. Initially,
such loci were selected on the basis of increased variability
(190th percentile) in the sperm DNA–HHA data set; in
addition, a number of these loci were also highly variable
in the sperm DNA–HpaII data set (CDH13, SCAM1, MKL2,
and DIRAS3). Each of the 12 loci selected were initially
resequenced to confirm the identity of the sequence. DNA
samples from 11 individuals were treated with sodium
bisulphite and were PCR amplified, and primer extension
reactions were performed to interrogate 65 CpG dinu-
cleotides within the 12 sequences. Examples of six loci are
presented in figure 7. This analysis revealed variable levels
of methylation differences in at least one enzyme-restric-
tion site in 11 of 12 loci tested. It should be noted here
that DNA methylation differences in a single restriction
site may be sufficient to generate significant differences
in the microarray analysis. Only one locus (DIRAS3)
showed no methylation differences between the 11 in-
dividuals; however, we were able to test only 5 of 20 CpG
sites at this locus, so methylation variation in the untested
CpG sites cannot be ruled out. To assess the replicability
of the assay, we repeated the MS-SNuPE/SNaPshot exper-
iment on five loci in five individuals. Consistent with pub-
lished data,27 the results in this second round of experi-
ments were within 5% of the first experiment, on average
(range 1.7%–9.9%).
Finally, for further validation of the MS-SNuPE meth-
od and microarray results, we performed bisulphite ge-
nomic sequencing of 30 clones from five individuals on
a locus within the gene that encodes cadherin 13
(CDH13 [University Health Network accession number
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Figure 6. Repetitive-element analysis in sperm DNA–HpaII and brain DNA–HpaII data sets. The microarray loci that contain a single
repetitive element were separated into each repeat class, and the mean CV (SD) was calculated (A). The repeat classes include DNA
transposons ( ), long interspersed transposable elements (LINEs [ ]), low-complexity repeats ( ), long terminalnp 209 np 771 np 461
repeats (LTRs [ ]), satellites ( ), simple repeats ( ), SINEs ( ), small nuclear RNA (snRNA [ ]),np 360 np 208 np 346 np 1,058 np 30
and tRNA ( ), and the nonrepetitive loci ( ) are presented for comparison. The satellite repeats were the only class tonp 40 np 6,976
show significantly increased variability in the sperm DNA–HpaII ( ) and less-significantly increased variability in the17Pp 6.12# 10
brain DNA–HpaII ( ) data sets. B, Breakdown of the satellite repeats into specific satellite-repeat classes, which reveals aPp .0027
number of repeat classes with increased variability—predominantly, the centromeric satellite repeats, including (GAATTC)n (Pp
; ), ALR/a ( ; ), CER ( ; ), and HSATII repeats ( ;17 25 58.44# 10 np 55 Pp 4.08# 10 np 119 Pp .0026 np 6 Pp 3.91# 10 np
) but not BSR/b repeats ( ; ).19 P 1 .05 np 7
UHNhscpg0004063]). This analysis revealed a clear-cut bi-
modal distribution of epialleles, with the majority of clone
sequences being either mostly methylated across all 16
CpG dinucleotides tested or predominantly unmethy-
lated. In addition, this sequencing analysis identified a
SNP, C/G—also identified in dbSNP as rs16961372—with
a rare C allele frequency of 0.396 in whites. Of the five
individuals sequenced, one was homozygous C, one was
homozygous G, and the other three were C/G heterozy-
gous (fig. 8). Of particular interest is the substantially
higher density of methylated cytosines on the G allele,
whereas the C alleles predominantly exhibit a low degree
of methylation. Counting all clones across all five in-
dividuals together, we found that 67 (77%) of 87 of the
sequences with the G allele were methylated, whereas only
14 (22%) of 63 sequences containing the C allele were
methylated ( ; ).2 10x p 40.4 Pp 2.08# 10
Given that the microarray analysis suggested that pro-
moter CpG islands were significantly more variable, we
also performed bisulphite genomic sequencing of the pro-
moter CpG island of CDH13, which was not represented
on the CpG microarray. This analysis, however, found that
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Table 5. List of Clones Selected for Bisulfite-Modification MS-SNuPE Analysis
University
Health Network
Accession Number Gene Gene Description
Chromosome
Location
Total
Enzyme
CpGsa
CpGs
Testedb
Variable
Methylated
CpGsc
UHNhscpg0004931 OLR1 Oxidized low-density lipoprotein receptor 1 12p13.2 12 11 9
UHNhscpg0004063 CDH13 Cadherin 13 preproprotein 16q23.3 8 8 8
UHNhscpg0002847 SCAM1 Sorbin and SH3 domain–containing 3 8p21.3 13 6 5
UHNhscpg0003990 NELL2 NEL-like 2 (chicken) 12q12 2 2 2
UHNhscpg0003907 NEIL2 Nei-like 2 (Escherichia coli) 8p23.1 7 6 4
UHNhscpg0001947 MKL2 Megakaryoblastic leukemia 2 16p13.12 10 5 2
UHNhscpg0000823 2-PDE 2′-Phosphodiesterase 3p14.3 20 6 1
UHNhscpg0004641 RHOQ Ras-related GTP-binding protein TC10 2p21 12 6 1
UHNhscpg0002006 DIRAS3 Ras homolog gene family, member I 1p31.2 20 5 0
UHNhscpg0005090 AHR RWD domain–containing 3 1p21.3 3 3 2
UHNhscpg0009548 DSCAM Down syndrome cell-adhesion molecule 21q22.2 4 3 3
UHNhscpg0004745 FBN1 Fibrillin 1 (Marfan syndrome) 15q21.1 2 2 2
a The number of CpG sites within the recognition sequence of restriction enzymes HpaII, Hin6I, and AciI.
b The number of CpG sites tested by MS-SNuPE.
c The number of CpG sites that showed variable methylation between individuals.
the promoter CpG island of CDH13 is predominantly un-
methylated in all individuals, with only solitary methyl-
ation sites present in one to three clones for each of the
individuals.
Discussion
In this study, we performed an in-depth analysis to address
the question of epigenetic variability in the germline. The
main conclusions are that (1) the male germline exhibits
locus-, cell-, and age-dependent DNA methylation differ-
ences and that (2) DNA methylation variation is signifi-
cant across unrelated individuals, at a level that, by far,
exceeds DNA sequence variation. These findings are in-
teresting from both basic molecular biological and bio-
medical points of view.
First, our study contributes to the understanding of ep-
igenetic peculiarities of gene regulatory regions in the
germline. It has been generally accepted that CpG islands
are predominantly unmethylated,36 which implies that
DNA methylation differences would not be expected
there. From our studies, we find that even relatively low
densities of methylated cytosines in the CpG islands are
sufficient to generate unique epigenetic profiles in DNA
regions that do not exhibit any DNA sequence variation,
both in different cells of the same individual and also
across individuals. Fine-mapping of methylated cytosines
of relatively short DNA fragments of BRCA1, BRCA2,
PSEN1, PSEN2, DM1, and HD suggest that each sperm cell
is unique not only in terms of DNA sequence but also in
epigenomic profile, and variation of the latter by far ex-
ceeds the former.
At the genomewide level, unexpectedly, promoter CpG
islands exhibited larger interindividual variation com-
pared with other single-copy DNA sequences, including
the non–promoter CpG islands. This epigenetic phenom-
enon seems to be discordant, with a general rule that func-
tionally important loci exhibit a low degree of DNA var-
iation, as is seen in the case of SNPs being less common
in promoters and exonic sequences than in introns and
intergenic regions. In addition, promoter CpG–rich re-
gions are often highly conserved between species; for in-
stance, the mouse genome contains 15,500 CpG islands,
of which ∼10,000 are highly conserved.37 Therefore, if the
epigenetic variability were just “noise” of little functional
relevance, one would expect more variability in these less
biologically important regions, such as introns and inter-
genic sequences. Evidence of the opposite—increased epi-
genetic variability in the regions that directly control gene
activity—may indicate some peculiarities of DNA meth-
ylation machinery during gametogenesis that may or may
not be of functional importance in the somatic cells (see
below for discussion of the postzygotic [in]stability
of inherited epigenetic profiles).
Our study has also identified a larger degree of inter-
individual variability of centromeric satellite repeats. Al-
though we cannot strictly rule out the possibility of DNA
copy differences, which are common in centromeric sat-
ellite repeats,38 the fact that the germ cell data set showed
substantially larger CVs in comparison with the brain
DNA data set suggests that germline satellite methylation
differences in the germ cells could be a genuine biological
phenomenon. Interindividual methylation variability in
satellite repeats is consistent with current knowledge39 and
may contribute to phenotypic variability in immunode-
ficiency-centromeric instability-facial anomalies syn-
drome (ICF [MIM 242860]), a disease that is associated
with methylation defects in pericentromeric satellites.40 In
addition, microRNAs (or siRNAs) regulate gene expression,
heterochromatin formation, and genome stability and of-
ten arise from demethylation of tandem repeats that are
common in pericentromeric sequences.41 Therefore, in-
terindividual methylation variability in tandem repeats
that give rise to microRNAs could also be involved in the
variability in gene expression that results in inherited phe-
notypic variation. A recent study has described increased
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Figure 7. MS-SNuPE analysis of densities of methylated cytosines in CpG dinucleotides of selected genes. Genomic DNA from 11
individuals was treated with sodium bisulphite and then was PCR amplified for each gene. The genes NELL2, SCAM1, NEIL2, MKL2, CDH13,
and OLR1 are represented. The methylation status of CpG dinucleotides within each of the restriction-enzyme sites was interrogated
using the primer-extension reactions. Methylation of each of the CpG dinucleotides is represented as a percentage of methylated PCR
products: completely unmethylated (white circles), partially methylated (partially black circles), or completely methylated (black circles).
interindividual variability in the methylation of Alu re-
peats42 in whole-blood DNA, a finding that was not ob-
vious in our analysis of germ cells, in which short inter-
spersed transposable elements (SINEs) were not statis-
tically different from nonrepetitive elements. However,
Sandovici et al. noted that the parental-origin differences
in methylation were identified only for Alu elements in
pericentromeric chromosomal bands,42 which is consis-
tent with our results.
Second, epigenetic variation within and across germline
samples could be of significant interest in human morbid
genetics, which, thus far, has nearly exclusively concen-
trated on DNA sequence differences. Inherited epigenetic
variation may provide the basis for new hypotheses and
experimental designs in the studies of various human dis-
eases, where the traditional DNA sequence–based studies
are reaching the limit of explanatory power. For example,
although Huntington disease (HD) is caused by trinucle-
otide-repeat expansion in the HD gene, the correlation
between the number of trinucleotide repeats and age at
onset for patients with later-onset HD (at age 150 years)
is low.43 The epigenetic status of the HD promoter region
may contribute to the steady-state HD mRNA levels and,
therefore, to the production of toxic polyglutamine-con-
taining proteins. HD genes containing identical trinucle-
otide-repeat expansion but differential DNA methylation
and chromatin compaction in the promoter region may
exhibit significant differences, in terms of their patho-
genic potential reflected in the age at disease onset and
severity of disease.
The role of differential germline epigenetic modification
in complex non-Mendelian disease may be even more crit-
ical. Despite significant efforts over the past several de-
cades, DNA sequence–based risk factors have been uncov-
ered in only a small fraction of complex diseases, such as
familial breast cancer and early-onset Alzheimer disease.
For a number of complex diseases, genetic epidemiological
studies showed that DNA sequence differences account for
only a small proportion of phenotypic variance among
relatives, whereas the substantial remaining fraction of
phenotypic differences (in some cancers, 58%–82%44) are
typically attributed to environment. Identification of
causal environmental factors is very difficult because
methodologically impeccable designs in epidemiological
studies, as a rule, cannot be applied to humans.45 At the
same time, there is an increasing body of evidence that
environmental factors play a minimal role in a number
of complex traits and disease conditions.46 In this context,
epigenetic variation in the germline arises as a new mo-
lecular mechanism that may help the understanding of
complex phenotypes that are not the outcome of DNA
sequence variation or differential environment. The re-
cent finding of germline epimutations of MLH1 in three
individuals affected with multiple cancers11,47 provides a
good starting point for a systematic search for disease-
specific epimutations in the germline.12
In our bisulphite modification–based analyses, the over-
whelming majority of loci exhibited rather subtle DNA
methylation differences (“shades of gray” type), whereas
methylation of the locus within CDH13 is clearly bimodal
(“black or white” type). The cadherin gene is a putative
mediator of cell-cell interaction in the heart and may act
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Figure 8. Methylation profiles of CDH13. Methylation status of 16 CpG sites surrounding the CDH13 C/G SNP across 30 clones sequenced
in each of five tested individuals. Seventy-seven percent (67/87) of the G alleles are methylated (four or more methylated CpGs),
whereas 78% (49/63) of the C (bisulphite-converted to T) alleles are unmethylated. The first seven CpG dinucleotides interrogated by
MS-SNuPE in figure 7 are represented in this figure as CpGs 5, 6, 9, 10, 13, 15, and 16. CpG 9 is the third MS-SNuPE primer that was
predominantly unmethylated in all individuals. Each individual is represented, with single CpG dinucleotides from left to right (black
p methylated; white p unmethylated) and with individual clones from top to bottom.
as a negative regulator of neural cell growth. This gene is
not imprinted; however, the promoter is hypermethylated
in numerous cancers.48–53 Of particular interest is the find-
ing that DNA methylation profiles are associated with
DNA alleles; the C allele of CDH13 is predominantly un-
methylated, whereas the G allele is predominantly meth-
ylated. To our knowledge, only a few human studies have
identified associations between DNA sequence and epi-
genetic profiles. In Beckwith-Wiedemann syndrome, loss
of maternal allele–specific methylation was more com-
mon on the G allele at the T382G SNP (CAGA haplotype)
of the differentially methylated region KvDMR1.54 A com-
mon variant, 677CrT, at the 5′ 10-methylenetetrahydro-
folate reductase gene (MTHFR), is associated with an in-
creased risk of imprinting defects in the Prader-Willi
syndrome/Angelman syndrome region of 15q.55 A com-
prehensive screen of chromosome 21q has identified a
single CpG island with a C/G SNP that was methylated
in peripheral blood DNA on the C allele, regardless of the
parent of origin.56 Finally, the C102T polymorphism in
the serotonin 5-HT2A receptor gene (5HT2AR), which has
been associated with several psychiatric disorders, was
methylated specifically on the C allele.57 In mice, a recent
study identified a number of genes that, on in vitro mu-
tation, affect epigenetic reprogramming during gameto-
genesis and early development on a genomewide level,
suggesting a further mechanism by which DNA sequence
(mutations) in trans can affect the epigenetic state.58 A
comprehensive epigenetic analysis of SNPs is warranted,
and this effort may shed a new light on rather inconsistent
genetic association studies in complex disease. Epialleles
and epihaplotypes that combine both DNA sequence and
epigenetic information may be better predictors of the risk
for a disease than any of the two components analyzed
separately.
A number of genes in the sperm exhibited DNA meth-
ylation changes that correlate with age (fig. 5 and tables
3 and 4). This finding is particularly interesting in light
of the evidence that older paternal age is associated with
risk for schizophrenia in the offspring.59,60 Although it has
been hypothesized that such effects could be due to epi-
genetic changes in the paternal genome, no locus-specific
and age-dependent epigenetic changes in the human male
germline have been identified thus far. In this study, a
number of genes that show age-related changes in their
DNA methylation have been detected, including a number
of important developmental genes. The embryonic ecto-
derm development gene, EED, is a polycomb group gene
involved in maintaining the epigenetically regulated re-
pressive state of developmental genes over successive cell
generations.61 CTNNA2, or catenin, is a neuronal cad-
herin-associated protein and may play a major role in the
folding and lamination of the cerebral cortex.62 CALM1,
or calmodulin, is a key calcium-modulated protein that
functions in growth and in the cell cycle, as well as in
signal transduction and in the synthesis and release of
neurotransmitters. STMN2, or stathmin-like 2, is a neu-
ronal growth-associated protein that shares significant
amino acid–sequence similarity with the phosphoprotein
stathmin, and CDH13, as described above, is the heart
cadherin and is hypermethylated in a number of cancers.
All the above phenotype-related aspects were discussed
under the assumption that the epigenetic peculiarities of
the germline are, at least to some extent, reflected in the
somatic cells after birth. What proportion and to what
extent these inherited epigenetic signals can “survive” the
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reprogramming that immediately follows fertilization, as
well as during the later stages of embryogenesis,13,63,64 re-
main to be investigated. The methylation clearing is not
complete and, on a global DNA level, is reduced to
∼10%.65,66 That could represent 90% of all methylation for
each gene being erased or could mean that 90% of meth-
ylated genes are completely cleared and that 10% of genes
retain their methylation, or there could be numerous com-
binations of the two. It is also unknown what happens to
the histone modifications through these phases of loss of
DNA methylation signals. Since modifications of DNA and
histones are codependent, even if the DNA methylation
signals are erased, the histones may be able to carry on
specific epigenetic messages to the next stage until the
DNA gets remethylated. This concept of cellular memory
through histone modifications has been demonstrated for
polycomb group proteins through H3K27 trimethyla-
tion.67 A combined analysis of both histone modifications
and DNA methylation dynamics, from zygote to postnatal
stage, is required for the understanding of the importance
of germline epigenetics to phenotypic outcomes.
The second aspect that will determine biological im-
portance of the epigenetic variation in the germline is
transgenerational epigenetic inheritance: can complex
DNA methylation patterns, at least to some extent, be
inherited from the parents and transmitted to the off-
spring? There is already experimental evidence demon-
strating epigenetic meiotic inheritance across different
species, such as yeast,68 Arabidopsis,69 Drosophila,70,71 and
mice.20,21 Although there is no doubt that transgenera-
tional epigenetic inheritance does exist, it is not clear if
this is limited to a few loci or if it is a common genome-
wide phenomenon.
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